Access expired on Wednesday, September 18, 2024
This content was originally shared by a registered user, but access has expired. Create a free account to gain permanent access to all PracticeUpdate content.
Already Have An Account? Log in Now
Microbiota Therapeutics for IBD: The Way Forward
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Microbiota therapeutics for inflammatory bowel disease: the way forward
Lancet Gastroenterol Hepatol 2024 May 01;9(5)476-486, L Bethlehem, MM Estevinho, A Grinspan, F Magro, JJ Faith, JF ColombelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.